若弋生物

若弋生物

若弋生物

Biotech/Healthcare

Ruoyi Bio develops delivery technologies for macromolecular therapeutics and applies them to biopharmaceutical R&D. Its core platform is a drug delivery technology based on zinc finger proteins (ZFPs), while its lead pipeline consists of recombinant protein therapeutics targeting neuromuscular…

Latest round: Pre Series A (2023)

Source: ChinaBulls — chinabulls.com

Last updated 2023-03-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.